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Abstract
While the semen analysis has traditionally been relied upon to differentiate fertile and infertile men, its utility has been
questioned in the current era of assisted reproductive technologies. The desire for more sophisticated diagnostic and
predictive tools has led to increased use of sperm DNA damage in the management of male infertility. Despite the
availability of numerous assays to measure sperm DNA damage, our understanding of the etiology, measurement, and
clinical implications of sperm DNA damage remains incomplete. While the current evidence is fraught with heterogeneity
that complicates attempts at comparison and meta-analysis, there does appear to be a role for sperm DNA damage in
the development and maintenance of pregnancy in the era of in vitro fertilization (IVF) and intracytoplasmic sperm
injection (ICSI). However, as noted by the American Society for Reproductive Medicine, the routine and widespread use of
sperm DNA damage testing is not yet supported. Further studies are needed to standardize the measurement of sperm
DNA damage and to clarify the exact role of sperm DNA damage within the myriad of other male and female factors
contributing to reproductive outcomes in IVF and ICSI.
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Résumé
Si l’analyse de sperme a traditionnellement reposé sur la distinction des hommes féconds des inféconds, son utilité
a été remise en question à notre époque d’assistance médicale à la procréation.
Le souhait d’outils diagnostiques et prédictifs plus sophistiqués a mené à une utilisation croissante de l’altération de l’ADN
spermatique dans la prise en charge de l’infécondité masculine. Malgré la présence de nombreux tests disponibles pour
évaluer l’altération de l’ADN spermatique, notre compréhension de l’étiologie, de la mesure et de des implications cliniques
reste incomplète.
Bien que la preuve actuelle soit entachée d’une hétérogénéité qui complique les tentatives de comparaison et
de méta-analyses, l’altération de l’ADN semble bien avoir un rôle dans le développement et le maintien de la grossesse à
notre époque de fécondation in vitro (FIV) et d’injection intra cytoplasmique d’un spermatozoïde (ICSI). Toutefois, comme
l’a fait remarquer l’American Society for Reproductive Medicine, une large utilisation de l’évaluation de l’altération de
l’ADN en routine manque encore de support. De futures études sont nécessaires pour la standardisation de la mesure de
l’altération de l’ADN et pour élucider le rôle exact de cette altération parmi la myriade des autres facteurs masculins et
féminins qui contribuent aux issues reproductives de la FIV et de l’ICSI.
Mots clefs: FIV, ICSI, Spermatozoïde, Fragmentation de l’ADN, Halo, SCSA, Comet, TUNEL
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Background
The semen analysis has traditionally been used to differen-
tiate fertile and infertile men. With the advent of IVF and
ICSI, there has been a desire for more sophisticated diag-
nostic and predictive tools. Sperm DNA damage has been
associated with adverse reproductive outcomes and has
been increasingly used in the management of male infer-
tility in the era of IVF and ICSI. However, despite the
availability of numerous laboratory assays to measure
sperm DNA damage, the clinical utility of these tests and
their potential roles in the algorithm of male infertility
management have yet to be established.
This review seeks to examine the existent literature to
discuss our current understanding of sperm DNA damage,
the tools available for measuring sperm DNA damage,
and their associations with reproductive outcomes after
use of IVF and ICSI in an attempt to clarify the role of
these tests in the management of male infertility.
Methods
An extensive computer search of MEDLINE, EMBASE,
and PUBMED was performed using combinations of the
following search terms: “semen analysis,” spermiogenesis,”
“sperm DNA fragmentation,” “sperm DNA damage,” “IVF,”
“ICSI,” “outcomes,” “pregnancy,” “Comet,” “TUNEL,”
“SCSA,” SCD,” and “Halo.” Reference lists of relevant
articles and reviews were also analyzed for further articles.
After review of titles and abstracts, a list of relevant articles
that discussed semen analysis, sperm DNA fragmentation,
and the relationship between semen analysis and/or sperm
DNA fragmentation on reproductive outcomes was
compiled and included in the review.
The inadequacy of semen analysis
Along with a complete history and physical exam, semen
analysis is the diagnostic pillar for the assessment of male
fertility and, thanks to the efforts of the World Health
Organization (WHO), has been standardized worldwide.
To develop the currently used semen analysis reference
ranges, the WHO analyzed semen data from over 4500
men in fourteen countries and selected those that came
from 1859 fertile men, defined as those who were able to
impregnate their partners within twelve months of unpro-
tected sexual intercourse [1]. From there, the researchers
applied a one-sided lower reference limit of the 5th
percentile to establish the lower thresholds of a normal
semen analysis based on semen volume (1.5 mL), sperm
concentration (15 million sperm/mL), total sperm number
(39 million sperm/ejaculate), total progressive motility
(40 %), morphologically normal sperm (4 %), and sperm
vitality (58 %). Unfortunately, while providing a lower
thresholds of semen parameters in fertile men, this
methodology fails to address the more relevant clinical
question of the semen parameters that represent male
subfertility or infertility. Indeed, with 7.5 % of men
estimated to have fertility problems where a male factor
contributes to infertility, even the arbitrary lower reference
limit of 5 % for lower levels of abnormal semen parame-
ters is severely flawed.
Efforts to identify specific semen parameters able to
discriminate between fertile and subfertile men have mainly
used time-to-pregnancy (TTP) as a surrogate for fecundity
in couples desiring natural conception. The recent Longitu-
dinal Investigation of Fertility and the Environment (LIFE)
study was a prospective, observational cohort study that
assessed 501 couples discontinuing contraception with the
goal of becoming pregnant with TTP as the primary end-
point. While several semen parameters were associated
with differing TTP on univariate analysis, none of the
semen parameters reached significance on multivariate
analysis [2]. However, increasing male age was associated
with decreased fecundity on multivariate analysis (fecund-
ability odds ratio 0.96, 95 % CI 0.93–0.99) [2]. The results
from the LIFE study corroborate earlier work attempting to
define semen parameters indicative of male infertility.
These studies found that while semen parameters were
associated with fecundity, neither sperm concentration,
morphology, nor motility could be considered diagnostic of
infertility either alone or in combination [3]. The limita-
tions of semen analysis have been further reinforced by
studies showing that 15 % of those with normal semen
analyses by WHO criteria have infertility while other men
with abnormal semen parameters are fertile and able initi-
ate a pregnancy naturally [4, 5].
In the current era of assisted reproductive techniques
where technology can help overcome defects in sperm
function, the value of semen analysis has become even
more dubious. Initial reports of intracytoplasmic sperm
injection (ICSI) hailed its ability to bypass the natural
selection process and enable men with severely impaired
semen parameters to achieve both clinical pregnancy
and live birth. In his initial paper, Palermo reported that
neither sperm concentration, progressive motility, nor
morphology had any impact on ICSI outcomes [6].
Further case series corroborated Palermo’s early findings,
with studies reporting that neither oligospermia, asthenoo-
zospermia, teratoozospermia, nor oligoasthenoteratoozos-
permia had any impact on fertilization or pregnancy rates
in ICSI [7–10]. The only sperm parameter that appeared to
have a negative impact on ICSI outcomes was the use of a
totally immotile, or presumably dead, spermatozoon [8].
However, more recent experience has started to suggest
that ICSI may not be as effective in some cases with
impaired semen parameters, with case series reporting
significant deleterious effects on clinical pregnancy rates
with ICSI for men with severe asthenoozospermia [11],
teratoozospermia [12], and cryptoozospermia [13]. The
conflicting evidence on the ability of semen analysis to
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predict ICSI outcomes reinforces the inadequacy of semen
analysis as a measure of male subfertility and stresses the
need for a more robust and sophisticated marker for male
subfertility.
Sperm DNA damage
The limitations of semen analysis have led to the investi-
gation of sperm DNA damage as a potential marker for
male subfertility. The packaging of DNA within the sperm
head is the result of a complicated process requiring
extensive compaction and remodeling of the chromatin.
Unlike in somatic cells, where DNA is complexed with
histones into organizational units called nucleosomes, the
DNA in sperm cells is disassembled from the nucleosomal
structure with the somatic nucleosomal histones replaced
by small basic proteins called protamines during spermio-
genesis [14]. As hypothesized by Aitken, while fully prota-
minated sperm DNA is highly stable and resistant to
damage, deficiencies in protamination leave the DNA
poorly compacted and more prone to damage [15]. During
the chromatin packing process, single-strand and double-
strand breaks are naturally induced to allow unwinding of
the nucleosomal structure and again to avoid supercoiling.
However, these strand breaks are thought to be repaired
to prevent the persistence of DNA damage in mature
spermatozoa. Defects that affect DNA repair during DNA
compaction and packaging may also contribute to sperm
DNA damage.
Incomplete apoptosis is thought to be another
potential etiology for sperm DNA damage [16]. As in
somatic cells, abnormal sperm are programmed to
undergo apoptosis. However, because they are tran-
scriptionally and translationally inert, the apoptotic
pathways do not continue to completion. The initiated
apoptotic process causes the release of reactive oxygen
species (ROS) and the induction of sperm DNA
damage, resulting in the release of sperm with elevated
levels of DNA damage [16].
The post-testicular environment may also play a role in
sperm DNA damage, potentially through the action of
ROS [15]. Studies have found increased levels of sperm
DNA damage in men with longer abstinence periods while
other studies have found higher levels of sperm DNA
damage in ejaculated sperm when compared to testicular
sperm [17]. Animal studies have also suggested a role for
the post-testicular environment in sperm DNA damage.
Sugunuma et al. used a well-characterized murine model
for abnormal spermatogenesis to investigate the origin of
sperm DNA damage. He found that in infertile animals,
sperm harvested from the cauda epididymis or ejaculate
had higher levels of DNA damage and resulted in
decreased fertilization rates when compared to sperm
harvested from the testicle or caput epididymis, suggesting
that DNA damage occurred during epididymal transit
[18]. These findings were the first to challenge the para-
digm that the epididymal environment protected and pro-
moted the maturation of sperm and suggested that
epididymal transit could, in fact, further damage sperm in
men with defective spermatogenesis. The contribution of
the post-testicular environment to sperm DNA damage
has also been demonstrated more recently by Gawecka
et al., who showed that luminal fluid within the epididymis
and vas deferens can activate sperm chromatin fragmenta-
tion in mice [19].
Unfortunately, while significant strides have been made
in our understanding of sperm DNA integrity and damage,
the exact cause and origin of sperm DNA damage remains
unknown.
Measuring sperm DNA damage
There are a variety of tests available to measure sperm
DNA damage, including Comet, sperm chromatin
dispersion (SCD or Halo), sperm chromatin structure
assay (SCSA), and terminal deoxynucleotidyl transferase-
mediated deoxyuridine triphosphate-nick end labeling
(TUNEL). While each of the tests assess sperm DNA
damage, they are not equivalent, with each analysis
measuring a slightly different aspect of DNA damage
(Table 1). Indirect tests for sperm DNA damage include
SCD and SCSA while Comet and TUNEL are direct
tests of sperm DNA breaks.
Sperm chromatin dispersion (SCD or Halo)
SCD functions on the principle that when sperm are
placed in agarose, denatured in acid, and then exposed
to a lysing solution to remove DNA-associated pro-
teins, those with intact DNA will disperse around the
nucleus (thereby producing a halo around the nucleus)
whereas those with fragmented DNA will not disperse.
Sperm with fragmented DNA are prone to the induc-
tion of single-strand DNA (ssDNA) motifs during the
acid denaturation step and give rise to sperm with
nondispersed nuclei (very small or absent halos) when
viewed under a microscope [20]. The SCD result
represents the percentage of sperm present with
nondispersed nuclei.
SCD only detects ssDNA motifs created during the
acid denaturation step and fails to detect altered bases
[20]. While these ssDNA motifs can be created from
both single- and double-strand DNA fragments during
the acid denaturation step, SCD cannot discriminate the
type of DNA fragmentation or quantify the amount of
DNA damage at the level of the individual spermato-
zoon. On the other hand, as an assay that does not
depend on colour or fluorescence, SCD is simple, fast,
and reliable and does not require an experienced
operator to interpret or analyze the results.
Bach and Schlegel Basic and Clinical Andrology  (2016) 26:15 Page 3 of 10
Sperm chromatin structure assay (SCSA)
Like SCD, SCSA also starts with an acid denaturation step
and depends on the principle that abnormal DNA is more
prone to further fragmentation by acid denaturation than
intact DNA. Unlike SCD, SCSA uses a change in fluores-
cence by acridine orange to differentiate between sperm
with fragmented DNA versus those with intact DNA.
Acridine orange fluoresces green when bound to double-
strand DNA (dsDNA) but changes to red when bound to
ssDNA. A flow cytometer is then used to detect the
proportion of sperm with green versus red fluorescence
and determine the percentage of sperm with fragmented
DNA [21].
Like SCD, SCSA can only detect ssDNA motifs
created during the acid denaturation step and can
neither discriminate the type of DNA fragmentation
nor quantify the amount of DNA damage at the
level of the individual spermatozoon [21]. Since it
requires flow cytometry to detect the change in
acridine orange fluorescence from green to red, it is
also more expensive and requires experienced opera-
tors to conduct the assay and interpret the results.
Since its introduction in 1980, SCSA has been exten-
sively researched, with various studies attempting to
define threshold values. Unfortunately, variations in SCSA
protocols, artificial reproductive techniques, and patient
populations has led to varying thresholds, including 20,
27, and 30 % [22–24]. While there can be considerable
intra-individual variability of 30 % in sperm DNA damage
as measured by SCSA, clinically meaningful differences
that move a patient from likely to achieve pregnancy in
IVF to unlikely to achieve pregnancy in IVF occurs in only
11 % of patients [25].
Comet assay
The Comet assay relies on gel electrophoresis to quan-
tify the amount of DNA damage within an individual
spermatozoon. First, the sperm membrane is lysed and
the DNA decondensed in a high-concentration salt
environment that helps break down disulphide bridges
to remove DNA-associated proteins. In an alkaline elec-
trophoretic field, charged broken DNA strands migrate
to the cathode, leaving uncharged, unbroken DNA
strands behind. The resulting image resembles a comet,
with the tail of broken DNA strands trailing away from
a head of unbroken DNA strands. A fluorescent dye that
binds DNA (such as SYBR green 1) is applied to the
slides to enable visualization of the assay by fluorescent
microscopy [26].
The Comet assay is able to detect both single- and
double-strand DNA breaks as well as altered bases and
can detect breaks with both protamine-associated and
histone-associated chromatin [26]. Since the Comet
assay measures the quantity of DNA damage in an indi-
vidual spermatozoon, the reported Comet assay results
represent the mean damage from groups of individual
spermatozoa, with only 50 spermatozoa being needed to
obtain a reliable and repeatable result [26]. Compared to
other assays, the Comet assay is simple and cheap to
perform, but as its interpretation depends on fluorescent
Table 1 Comparison of assays measuring sperm DNA fragmentation
Assay Method of detection Advantages Disadvantages
SCD/Halo
[20]
• Sperm loaded in agarose, denatured in acid solution,
stained and observed with fluorescence microscopy
for chromatin dispersion/halos.
• Sperm with nondispersed chromatin (ie small halos)
have fragmented DNA.
• Interpreted as percentage of sperm with nondispersed
chromatin.
• Commercial assay available
• Interpretation does not depend
on fluorescence or flow cytometry
• Indirect assay only detects
ssDNA breaks
• Involves acid denaturation
SCSA
[21]
• Acid denaturation, then staining with acridine orange
and measurement with flow cytometer.
• Green-staining sperm have intact DNA while red-staining
sperm have denatured DNA.
• Interpreted as percentage of red-staining sperm
(denatured sperm).
• Has extensive body of literature
and established clinical thresholds
• Can be performed in fresh or frozen
samples
• Proprietary protocol with no
commercial assay available
• Indirect assay only detects
ssDNA breaks
• Involves acid denaturation
Comet
[26]
• With gel electrophoresis, fragmented DNA forms tail
while intact DNA stays in head.
• Can be performed in alkaline or neutral conditions.
• Tail size correlates to amount of DNA fragmentation
within individual spermatozoon.
• Interpreted as mean amount of DNA damage per
individual spermatozoon.
• Requires small number of sperm cells
• Direct assay can examine damage at
level of individual spermatozoon
• Can detect multiple types of DNA
fragmentation
• No established standardized
protocol
• Time and labour intensive
• Requires fresh semen sample
TUNEL
[30]
• Labeled nucleotide added to sites of DNA fragmentation
with subsequent fluorescence measured by flow cytometry
or fluorescence microscopy.
• Fluorescent sperm have fragmented DNA.
• Interpreted as percentage of fluorescent sperm.
• Direct assay
• Commercial assay available
• Can be performed in fresh or frozen
samples
• Detects ssDNA and dsDNA breaks
• No established standardized
protocol
• Variable clinical thresholds in
literature
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microscopy, requires an experienced observer with spe-
cial equipment to analyze and interpret the slides. Fur-
thermore, the interpretation of numerous spermatozoon
Comet assays is a tedious and low-throughput process in
which only 600 Comet assays per hour may be assessed
manually whereas semi-automated systems can analyze
50 slides per day [26]. However, newer advances have
leveraged fully automated processes to improve the
speed of Comet analysis by more than 90 %, which may
improve the usability of Comet in larger cohorts of
patients [27].
Studies done by those currently marketing the Comet
assay have attempted to define clinical threshold values for
Comet predictive of clinical pregnancy in in vitro
fertilization (IVF) and intracytoplasmic sperm injection
(ICSI) while assessing the repeatability of the assay [28, 29].
They determined a threshold of 52 % for whole sperm,
above which point a pregnancy was unlikely to occur with
IVF (OR 76, 95 % CI 8.69–1714, RR 4.75) and at which
point they would recommend proceeding to ICSI [29]. In
203 couples undergoing IVF and 136 couples undergoing
ICSI, the authors found that live birth rates with IVF fell
from 33 % in those with DNA fragmentation <25 to 24 %
in those with DNA fragmentation between 25–50 % and to
13 % in those with DNA fragmentation >50 % (p = 0.007)
[28]. However, there did not appear to be any association
between sperm DNA damage as measured by Comet and
ICSI outcomes [28]. In their study, they found Comet to be
highly repeatable, with a variance of a single assay of
3.73 %, which fell to 2.65 and 2.17 % for duplicate and trip-
licate assays, respectively [28].
Terminal deoxynucleotidyl transferase-mediated
deoxyuridine triphosphate-nick end labeling (TUNEL)
TUNEL relies on the enzyme terminal deoxynucleo-
tidyl transferase (TdT) to incorporate a biotinylated
deoxyuridine triphosphate (dUTP) at the 3′-OH ends
found at ssDNA and dsDNA break sites within the
sperm DNA. Either flow cytometry or fluorescence
microscopy can then be used to assess the fluores-
cence, with sperm brightness proportion to the level
of DNA fragmentation. TUNEL results represent the
percentage of sperm with fragmented DNA within
the sample [30].
Unlike the previously described indirect tests of
sperm DNA damage, TUNEL binds directly to the
sites of both ssDNA and dsDNA breaks within the
sperm DNA and does not rely on an additional
denaturation step to induce breaks in the sperm DNA
[30]. However, like the indirect tests, TUNEL cannot
discriminate between the types of DNA fragmentation
and is not only expensive, but also labour-intensive
and requires experienced operators to perform and
interpret the results.
Of the tests for sperm DNA damage, TUNEL arguably
presents the most potential for variation and is the least
standardized. As a result, studies attempting to establish
threshold values have resulted in dramatically different
values ranging from 4 to 35 % [29].
The role of sperm DNA fragmentation in IVF and ICSI
Numerous studies have attempted to assess the associ-
ation between elevated sperm DNA fragmentation and
ART outcomes. Unfortunately, variations between sperm
DNA fragmentation assays, protocols, and thresholds
and differences in study populations have resulted in
systematic reviews and meta-analyses fraught with
heterogeneity and unable to come to robust conclusions.
To some degree, the controversy surrounding sperm
DNA fragmentation is expected. If a male factor that
adversely affects reproductive outcomes is present along-
side a female factor known to have a strong deleterious
effect on reproductive outcomes (such as increased
female age), then the stronger female factor may obviate
or even reverse the measurable adverse impact of sperm
DNA fragmentation on reproductive outcomes. Further-
more, many of the studies have grouped patients under-
going IVF and ICSI together despite differences between
the two techniques and have examined different clinical
endpoints such as clinical pregnancy, miscarriage, and
live birth.
The most recent systematic review and meta-analysis
investigated 56 studies broken up into IVF (16 studies),
ICSI (24 studies), and mixed IVF and ICSI (16 studies)
and measuring sperm DNA damage either by SCSA,
TUNEL, SCD, or Comet [31]. Overall, they found that
sperm DNA damage predicts poor clinical pregnancy
rates after IVF and/or ICSI (OR 1.68, 95 % CI 1.49–1.89,
p < 0.0001). When stratified by type of ART, the impact
of sperm DNA damage on clinical pregnancy persisted
(OR 1.65, 95 % CI 1.34–2.04, p < 0.0001 and OR 1.31,
95 % CI 1.08–1.59, p < 0.0068 for IVF and ICSI, respect-
ively) [31]. In keeping with other previously published
meta-analyses, this meta-analysis was limited by poorly
controlled female factors and a high study heterogeneity
(61 %, p < 0.001), making it hard to rely on the odds
ratios obtained. While acknowledging the limited trust-
worthiness of their odds ratios, the authors do attempt
to explore the clinical relevance of sperm DNA damage
in ART and note a greater clinical relevance for sperm
DNA in IVF than in ICSI. With a median positive pre-
dictive value (PPV) of 79 %, a median negative predictive
value (NPV) of 35 %, and a median clinical pregnancy
rate of 32 % in IVF, information gleaned from sperm
DNA damage can discriminate between expected IVF
clinical pregnancy rates of 21 % (positive result) and
35 % (negative result) [31]. On the other hand, from a
median PPV of 64 %, a median NPV of 40 %, and a
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median clinical pregnancy rate of 36 % in ICSI, sperm
DNA damage results can only discriminate between ex-
pected ICSI clinical pregnancy rates of 36 % (positive re-
sult) and 40 % (negative result) [31].
Another recent systematic review and meta-analysis also
sought to assess the effect of sperm DNA damage on live
birth rates in IVF and ICSI. The authors identified six
prospective cohort studies that investigated the impact of
sperm DNA damage on live birth rates, with three using
SCSA, two using TUNEL, and one using Comet to meas-
ure sperm DNA damage. Their meta-analysis for patients
undergoing IVF, which comprised four studies with 553
patients, found a significantly higher live birth rate for men
with low amount of sperm DNA damage than for those
with high levels of sperm DNA damage (RR 1.27, 95 % CI
1.05–1.52, p = 0.01) [32]. For patients undergoing ICSI, the
authors pooled results from five studies comprising 445
patients and again found a significant increase in live birth
rate for men with low levels of sperm DNA damage (RR
1.11, 95 % CI 1.00–1.23, p = 0.04) [32]. In an attempt to
control for female factors, the authors subsequently
conducted a subgroup analysis that included only studies
accounting for female factors (age and ovarian reserve).
They identified only two studies with a very limited number
of treated subjects, but found the impact of sperm DNA
damage on IVF live birth rates was amplified significantly
(RR 2.76, 95 % CI 1.59–4.80, p = 0.0003) whereas the
impact of sperm DNA damage on ICSI live birth rates
became nonsignificant (RR 1.08, 95 % CI 0.39–2.96) [32].
This systematic review and meta-analysis, which assessed a
highly clinically relevant outcome (live birth rate), suggests
that higher levels of sperm DNA damage have a significant
impact on live birth rates in IVF, but not in ICSI and advo-
cates for ICSI as a potential therapeutic option for men
with elevated levels of sperm DNA damage. Unfortunately,
one cannot derive a robust conclusion from this systematic
review as it is fraught with heterogeneity, with the six
studies using both different methods to assess for sperm
DNA damage and also different thresholds to define high
versus low sperm DNA damage.
Despite the limitations of the aforementioned systematic
review, its conclusions agree with some previously
published studies. In particular, Zhao et al. conducted a
systematic review and meta-analysis to investigate the
impact of sperm DNA damage on clinical pregnancy and
miscarriage rates in IVF and ICSI. The authors included
sixteen cohort studies with 3106 couples undergoing IVF
or ICSI and found a significant decrease in pregnancy rates
for men with high DNA damage undergoing IVF (OR 0.66,
95 % CI 0.48–0.90, p = 0.008) but not for those undergoing
ICSI (OR 0.94, 95 % CI 0.70–1.25) [33]. On the other hand,
they found a significant increase in miscarriage rates for
men with high DNA damage undergoing ICSI (OR 2.68,
95 % CI 1.40–5.14, p = 0.003), but not for those undergoing
IVF (OR 1.84, 95 % CI 0.98–3.46) [33]. Of note, the authors
also stratified their meta-analysis by sperm DNA damage
assessment method and found that the different tests for
sperm DNA damage behaved differently, with only sperm
DNA damage as detected by TUNEL being significantly
associated with decreased clinical pregnancy rates while
only TUNEL and SCSA were significantly associated with
increased miscarriage rates [33]. While this systematic
review focused on the surrogate outcomes of clinical preg-
nancy and miscarriage rates rather than live birth rates, it
echoes the review published by Osman et al. in suggesting
an impact of sperm DNA damage on clinical pregnancy
rates in IVF, but not in ICSI. On the other hand, despite the
meta-analysis capturing only 47 miscarriages in the ICSI
group and 70 miscarriages in the IVF group, it presents
contradictory results showing an association between
sperm DNA damage with higher miscarriage rates in ICSI,
but not IVF. A further important insight was the indication
that the various methods of measuring sperm DNA
damage are not equivalent. Again, the results of this
systematic review must be interpreted with caution due to
heterogeneity, with differing threshold values for high
versus low sperm DNA damage being used amongst the
included studies and with the review unable to account for
female factors.
Older systematic reviews and meta-analyses have looked
separately at the impact of sperm DNA damage on mis-
carriage rates [34, 35] or on clinical pregnancy rates [36].
Unlike Zhao’s meta-analysis, which suggests a different
impact for sperm DNA damage on IVF versus ICSI,
Robinson [34] and Zini [35] both found that the signifi-
cant associations between high sperm DNA damage and
miscarriage rates did not depend on the method of
fertilization used. Collins [36] similarly found a statistically
and clinically significant association between sperm DNA
damage and clinical pregnancy rates when they pooled
data from IVF and ICSI studies. However, when the
authors did subgroup analyses of IVF and ICSI studies
separately, they were unable to demonstrate any statisti-
cally significant impact of sperm DNA damage on clinical
pregnancy results [36]. Furthermore, while the effect of
sperm DNA damage on reproductive outcomes was statis-
tically significant, but not enough to change the decision
to pursue assisted reproduction, they concluded that
sperm DNA damage had limited clinical value in the
initial evaluation of the infertile male. All three of these
older systematic reviews face similar limitations as the
more recently published meta-analyses, with a great deal
of heterogeneity between the tests of sperm DNA damage
used, threshold values for high versus low sperm DNA
damage, control of female factors, and the use of surrogate
outcomes (like clinical pregnancy) rather than live birth
rate. Ultimately, as was noted by the American Society for
Reproductive Medicine in 2013, despite the multitude of
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systematic reviews trying to tease out the impact of sperm
DNA damage on outcomes in IVF and ICSI, heterogeneity
has prevented any robust conclusions from being drawn
on the clinical utility of sperm DNA damage prior to
treatment with IVF and ICSI [37].
A potential explanation for the disparate findings seen in
contemporary meta-analyses on the impact of sperm DNA
damage when assessing clinical pregnancy and miscarriage
rates in IVF and ICSI could lie in the difference in sperm
selection process between the two methods of fertilization.
Importantly, none of the methods of assessing sperm DNA
damage permits the evaluation of the individual spermato-
zoon that goes on to fertilize the oocyte via either method
of fertilization. In ICSI, sperm with normal morphology
and progressive motility are selected for injection, which
may improve fertilization and clinical pregnancy rates
when compared to IVF, when fertilization depends on the
natural selection of a healthy spermatozoon from a group
with a high proportion of abnormal sperm. Studies have
shown that in infertile men, morphologically normal motile
sperm have higher rates of sperm DNA fragmentation
(20–60 %) when compared to those in fertile men [38].
While sperm DNA damage appears to play a lesser role in
fertilization and early development than abnormalities in
centrosome function or oocyte-activation factor [39], the
higher miscarriage rates in ICSI may be suggestive of a late
paternal effect of abnormal sperm DNA fragmentation on
embryo development [40]. Amongst couples who become
pregnant, the natural selection of a spermatozoon in IVF
may allow the selection of a near normal spermatozoon
with lesser degrees of sperm DNA damage when com-
pared to the artificial selection process used in ICSI, in
which the selection of a morphologically normal motile
spermotozoon may still mask significant sperm DNA
damage that exert their influence not at fertilization, but
later during embryonic development [40]. Further evidence
of sperm DNA damage representing unmeasurable sperm
defects in the entire semen sample rather than simply in
the few severely damaged sperm detected in the test result
comes from the fact that despite processed semen samples
having lower levels of sperm DNA damage than neat (or
unprocessed) semen samples, only sperm DNA damage as
measured by SCSA in the neat (or unprocessed) semen
sample is predictive of reproductive outcomes [41]. On the
other hand, when using Comet, sperm DNA damage in
both the neat and processed semen samples are predictive
of reproductive outcomes [42].
While meta-analyses appear to uniformly suggest a dele-
terious impact for sperm DNA damage on clinical preg-
nancy and live birth rates in IVF, they are less clear on the
effect of sperm DNA damage on ICSI outcomes. Unfortu-
nately, the number of studies assessing ICSI alone is very
limited, which makes it difficult to analyze the true effects
of sperm DNA damage on ICSI results. Contemporary
studies looking at ICSI results alone have corroborated the
adverse effect of impaired sperm DNA integrity on ICSI
outcomes, with Esteves et al. showing higher miscarriage
and lower live birth rates in couples using ejaculated sperm
with high sperm DNA damage (mean DFI 40.9 %)
compared to those using testicular sperm with low sperm
DNA damage (mean DFI 8.3 %) in a prospective cohort
trial of 172 couples [43]. Similarly, Mehta et al. found that
50 % of couples who had previously failed one or more
IVF-ICSI cycles using ejaculated sperm with a high sperm
DNA damage (mean TUNEL 24.5 %) were able to achieve
both pregnancy and live birth with ICSI using testicular
sperm with low sperm DNA damage (mean TUNEL 4.6 %)
[44]. Taken together, this contemporary data suggests a
negative impact for high levels of sperm DNA damage on
ICSI results.
Implementing sperm DNA fragmentation into clinical
practice
While the appropriate place for sperm DNA fragmentation
in the clinical management of the infertile couple has yet to
be clearly elucidated, the growing body of evidence suggests
its utility in helping direct the management of the infertile
couple. Given the association between sperm DNA frag-
mentation and early miscarriage in ART, an elevated sperm
DNA fragmentation rate in the couple with recurrent ART
failure may point to a paternal cause. Even the non-
azoospermic couple with recurrent natural pregnancy loss
may benefit from investigation into sperm DNA fragmenta-
tion that could then predict IVF success and potentially
direct a couple to ICSI rather than IVF.
Therapeutic strategies to improve high levels of sperm
DNA fragmentation are unfortunately poorly understood.
Strategies that have been studied include oral antioxidant
medications, varicocele repair, and the use of testicular
sperm in ART. Unfortunately, while the evidence does
suggest potential benefit to these strategies in the manage-
ment of elevated sperm DNA fragmentation, the quality
of the evidence on the topic is limited by smaller studies.
The seminal paper examining the use of antioxidants to
manage elevated sperm DNA fragmentation was performed
by Greco et al. in 38 couples who had elevated sperm DNA
fragmentation and a failed ICSI cycle attempt. After treat-
ment with 2 months of daily vitamin C and vitamin E, 76 %
of men had a decrease in sperm DNA fragmentation from
>10 % on TUNEL to <10 % on TUNEL, which resulted in a
significantly improved clinical pregnancy rate (48.2 % vs
6.9 %, p < 0.05 for post-treatment with antioxidants and
pre-treatment with antioxidants, respectively) [45]. While a
recent Cochrane review suggested a positive impact of oral
antioxidants on live birth rates in couples attending fertility
clinics (OR 4.21, 95 % CI 2.08–8.51, p < 0.0001), the results
were based on a small amount of low quality data [46].
Only two studies included in the analysis looked at sperm
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DNA fragmentation, but noted an improvement in sperm
DNA fragmentation of 13 % with antioxidant therapy [46].
Since oxidative stress is posited as a potential patho-
physiological mechanism for varicocele on fertility, varico-
cele repair has also been touted as a potential strategy to
manage elevated sperm DNA fragmentation. Indeed, men
with varicoceles appear to have higher levels of sperm DNA
fragmentation and varicocele repair is often associated with
improvements in sperm DNA fragmentation [47]. However,
a meta-analysis revealed that the improvement in sperm
DNA fragmentation after varicocele repair was limited to
3.37 % (95 % CI 2.65–4.08 %, p < 0.000001), which may not
be clinically relevant [48].
The use of testicular sperm in ART for couples with
elevated sperm DNA fragmentation has also been inves-
tigated. Testicular sperm typically has lower levels of
sperm DNA fragmentation when compared to ejaculated
sperm [17]. As has been discussed earlier in this review,
both Esteves and Mehta have demonstrated improved
live birth rates in couples using testicular sperm with
lower levels of sperm DNA fragmentation rather than
ejaculated sperm for ICSI [43, 44].
In our practice, we test sperm DNA fragmentation in
couples who have recurrent pregnancy loss either by
natural conception or with ART. Our center typically tests
TUNEL and internal testing has shown good concordance
of our laboratory’s TUNEL results with reproductive
outcomes (unpublished data). Given the large body of
evidence behind SCSA, we also use SCSA as an adjunct
measure of sperm DNA fragmentation. For patients with
elevated levels of sperm DNA fragmentation, we advocate
the use of antioxidants and will also proceed with testicu-
lar sperm retrieval for use in ICSI for couples with recur-
rent pregnancy loss using ejaculated sperm with elevated
sperm DNA fragmentation.
Impact of sperm DNA fragmentation on offspring health
Another concern stemming from elevated sperm DNA
fragmentation revolves around its impact on offspring.
Given the novelty of sperm DNA fragmentation assays
and the fact that most ICSI children are only reaching
their 20s, the long term impact on offspring remains
unknown. Furthermore, ethical issues will likely render
high quality comparative studies in humans impossible,
currently leaving only evidence from animal models and
indirect extrapolations to address the question.
Animal studies in rodents have demonstrated that the
ICSI offspring derived from males with elevated sperm
DNA fragmentation are prone to abnormal growth and
behaviour, premature aging, and the development of
tumours during later life [49]. Indirect evidence of the
impact of sperm DNA fragmentation on offspring health
can be derived from studies linking paternal age and
smoking with offspring health. While no studies have
looked at the direct association between sperm DNA
fragmentation and offspring health in humans, studies
have linked both increasing paternal age and smoking
with increased sperm DNA fragmentation while other
studies have linked these paternal states to increased
incidences of childhood cancer, schizophrenia, and
neural tube defects in the offspring [50–54].
Ultimately, while current animal models and extrapola-
tive data in human studies raise concern of health problems
in the offspring derived from sperm with elevated levels of
DNA fragmentation, longitudinal data from current and
future ICSI offspring are required to obtain a fuller under-
standing of the impact of sperm DNA fragmentation on
offspring health.
Next steps and challenges
Our current efforts to understand the clinical utility of
sperm DNA damage on reproductive outcomes during IVF
and ICSI are currently being hampered by our poor under-
standing of sperm DNA damage, including the effects of
measured sperm DNA damage on other spermatozoa in
the semen sample that do not have clinically detectable
damage. Zhao’s finding that the different methods of asses-
sing sperm DNA damage behave differently is in agreement
with previous studies and highlights a major gap in our
knowledge of sperm DNA damage [33–36]. Our current
understanding of the clinical implications of sperm DNA
damage is at a nascent stage. As mentioned previously, we
do not yet definitively know the etiology of sperm DNA
damage nor do we know the true clinical implications of
the types or degree of sperm DNA damage on reproductive
outcomes. Without this knowledge, it is difficult to deter-
mine both the best clinical assay for sperm DNA damage
and the appropriate thresholds to use in order to
standardize our assessment of sperm DNA damage. An
increased understanding of the repair mechanisms and
capabilities for sperm DNA damage both during spermio-
genesis and within the oocyte during fertilization is also
needed. Finally, we remain unable to determine the genetic
status of the fertilizing spermatozoon and are currently un-
able to use our current assessments of sperm DNA damage
to help select sperm with intact DNA for ICSI. Once we
improve our understanding of sperm DNA damage and are
able to establish standardized methodologies and thresholds
to assess sperm DNA damage, we can then consider under-
taking large, prospective, randomized controlled trials to
truly assess the impact of sperm DNA damage on repro-
ductive outcomes in IVF and ICSI.
Conclusion
For many years, semen analysis has been the cornerstone
for evaluation of male infertility despite limitations of its
utility to predict reproductive outcomes in IVF and ICSI.
As a result, assessment of sperm DNA damage has been
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touted as a useful adjunct to help predict outcomes in IVF
and ICSI. Numerous large systematic reviews appear to
show relationships between sperm DNA damage and re-
productive outcomes in IVF and ICSI, though these reviews
are limited by the heterogeneity of the underlying studies
that make it difficult to draw definitive conclusions from
their analyses. While our understanding of the etiology,
measurement, and functional implications of sperm DNA
damage remains incomplete, these sperm DNA fragmenta-
tion tests provide additional information on the critical role
of sperm in the development and maintenance of a preg-
nancy. However, at this time, there is not yet definitive evi-
dence to support the routine and widespread use of sperm
DNA damage testing in general reproductive practice.
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